Recent studies also demonstrate the efficacy of combining CDK4/6 with HSP-90 inhibitors, further inhibiting HIF1 activity and offering potential treatment enhancements for renal and colon cancers (26). The gene discussed is HIF1A; the disease is malignant colon neoplasm.